Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2018

02.08.2018 | Melanoma

Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?

verfasst von: Matthew C. Perez, MD, Felipe R. de Pinho, MD, Amanda Holstein, BS, Daniel E. Oliver, MD, Syeda M. H. Naqvi, MD, MPH, Youngchul Kim, PhD, Jane L. Messina, MD, Erin Burke, MD, Ricardo J. Gonzalez, MD, Amod A. Sarnaik, MD, C. Wayne Cruse, MD, Evan J. Wuthrick, MD, Louis B. Harrison, MD, Vernon K. Sondak, MD, Jonathan S. Zager, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Guidelines regarding specific resection margins for primary Merkel cell carcinoma (MCC) are not well established. The current National Comprehensive Cancer Network (NCCN) guidelines recommend 1- to 2-cm resection margins. This study aimed to determine the impact of margin width on local recurrence (LR), disease-specific survival (DSS), overall survival (OS), and type of wound closure.

Methods

All patients who underwent resection of primary MCC at a single institution from 2000 to 2015 were reviewed. Patient demographics, clinicopathologic characteristics, treatments, and outcomes were reviewed.

Results

A total of 240 patients underwent resection of primary MCC with resection margin width identified in the operative report. The median age was 76 years, and 65.8% of the patients were men. Of the 240 patients, 85 (35.4%) had head and neck primaries, 140 (58.3%) had extremity primaries, and 15 (6.3%) had trunk primaries. In terms of margins, 69 patients (28.8%) had a margin of 1 cm, 36 patients (15%) had a margin of 1.1–1.9 cm, and 135 patients (56.2%) had a margin of 2 cm or more. The median follow-up period was 21 months. The LR rate was 2.9% for a margin of 1 cm, 2.8% for a margin of 1.1–1.9 cm, and 5.2% for a margin of 2 cm or more (p = 0.80). The 5-year OS was 63.6% for a margin of 1 cm, 59.7% for a margin of 1.1–1.9, and 70.7% for a margin of 2 cm or more (p = 0.66). The 5-year DSS was 80.3% for a margin of 1 cm, 66.2% for a margin of 1.1–1.9 cm, and 91.8% for a margin of 2 cm or more (p = 0.28). For wound closure, 43.5, 50, and 65.9% of the patients respectively required a flap or graft with a margin of 1, 1.1–1.9, and 2 cm or more (p = 0.006).

Conclusions

A 1-cm resection margins did not increase the risk of LR. Margin width did not make a significant difference in DSS or OS. Larger resection margins increase the need for a graft or flap closure.
Literatur
1.
Zurück zum Zitat Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107–10.CrossRef Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107–10.CrossRef
2.
Zurück zum Zitat Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, et al. Merkel cell carcinoma: current United States incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78:457–63.CrossRef Paulson KG, Park SY, Vandeven NA, Lachance K, Thomas H, Chapuis AG, et al. Merkel cell carcinoma: current United States incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78:457–63.CrossRef
3.
Zurück zum Zitat Swann MH, Yoon J. Merkel cell carcinoma. Semin Oncol. 2007;34:51–6.CrossRef Swann MH, Yoon J. Merkel cell carcinoma. Semin Oncol. 2007;34:51–6.CrossRef
4.
Zurück zum Zitat Rollison DE, Giuliano AR, Becker JC. New virus associated with Merkel cell carcinoma development. J Natl Compr Cancer Netw. 2010;8:874–80.CrossRef Rollison DE, Giuliano AR, Becker JC. New virus associated with Merkel cell carcinoma development. J Natl Compr Cancer Netw. 2010;8:874–80.CrossRef
5.
Zurück zum Zitat Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, et al. Merkel cell carcinoma, version 1.2014. J Natl Compr Cancer Netw. 2014;12:410–24.CrossRef Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, et al. Merkel cell carcinoma, version 1.2014. J Natl Compr Cancer Netw. 2014;12:410–24.CrossRef
6.
Zurück zum Zitat Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300–9.CrossRef Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300–9.CrossRef
7.
Zurück zum Zitat Doepker MP, Thompson ZJ, Fisher KJ, Yamamoto M, Nethers KW, Harb JN, et al. Is a wider margin (2 cm vs 1 cm) for a 1.01–2.0-mm melanoma necessary? Ann Surg Oncol. 2016;23:2336–42.CrossRef Doepker MP, Thompson ZJ, Fisher KJ, Yamamoto M, Nethers KW, Harb JN, et al. Is a wider margin (2 cm vs 1 cm) for a 1.01–2.0-mm melanoma necessary? Ann Surg Oncol. 2016;23:2336–42.CrossRef
8.
Zurück zum Zitat Ghadjar P, Kaanders JH, Poortmans P, Zaucha R, Krengli M, Lagrange JL, et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2011;81:e583–91.CrossRef Ghadjar P, Kaanders JH, Poortmans P, Zaucha R, Krengli M, Lagrange JL, et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2011;81:e583–91.CrossRef
9.
Zurück zum Zitat Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, et al. Radiation therapy is associated with improved outcomes in Merkel cell carcinoma. Ann Surg Oncol. 2016;23:3572–8.CrossRef Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, et al. Radiation therapy is associated with improved outcomes in Merkel cell carcinoma. Ann Surg Oncol. 2016;23:3572–8.CrossRef
10.
Zurück zum Zitat Kang SH, Haydu LE, Goh RY, Fogarty GB. Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma. Radiation Oncol London, England. 2012;7:171.CrossRef Kang SH, Haydu LE, Goh RY, Fogarty GB. Radiotherapy is associated with significant improvement in local and regional control in Merkel cell carcinoma. Radiation Oncol London, England. 2012;7:171.CrossRef
11.
Zurück zum Zitat Nahhas AF, Scarbrough CA, Trotter S. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2017;10:37–46.PubMedPubMedCentral Nahhas AF, Scarbrough CA, Trotter S. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2017;10:37–46.PubMedPubMedCentral
12.
Zurück zum Zitat Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318:1159–62.CrossRef Veronesi U, Cascinelli N, Adamus J, Balch C, Bandiera D, Barchuk A, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med. 1988;318:1159–62.CrossRef
13.
Zurück zum Zitat Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol. 1996;3:446–52.CrossRef Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol. 1996;3:446–52.CrossRef
14.
Zurück zum Zitat Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, et al. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer. 2000;89:1495–501.CrossRef Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, et al. Long-term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer. 2000;89:1495–501.CrossRef
15.
Zurück zum Zitat Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, et al. Long-term results of a prospective surgical trial comparing 2-cm vs 4-cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol. 2001;8:101–8.PubMed Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, et al. Long-term results of a prospective surgical trial comparing 2-cm vs 4-cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol. 2001;8:101–8.PubMed
16.
Zurück zum Zitat Thomas JM, Newton-Bishop J, A’Hern R, Coombes G, Timmons M, Evans J, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350:757–66.CrossRef Thomas JM, Newton-Bishop J, A’Hern R, Coombes G, Timmons M, Evans J, et al. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004;350:757–66.CrossRef
17.
Zurück zum Zitat Lens MB, Nathan P, Bataille V. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg. 2007;142:885–91. (discussion 91–3).CrossRef Lens MB, Nathan P, Bataille V. Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials. Arch Surg. 2007;142:885–91. (discussion 91–3).CrossRef
18.
Zurück zum Zitat Hudson LE, Maithel SK, Carlson GW, Rizzo M, Murray DR, Hestley AC, et al. 1- or 2-cm margins of excision for T2 melanomas: do they impact recurrence or survival? Ann Surg Oncol. 2013;20:346–51.CrossRef Hudson LE, Maithel SK, Carlson GW, Rizzo M, Murray DR, Hestley AC, et al. 1- or 2-cm margins of excision for T2 melanomas: do they impact recurrence or survival? Ann Surg Oncol. 2013;20:346–51.CrossRef
19.
Zurück zum Zitat Becker J, Mauch C, Kortmann RD, Keilholz U, Bootz F, Garbe C, et al. Short German guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges. 2008(6 Suppl 1):S15–6.CrossRef Becker J, Mauch C, Kortmann RD, Keilholz U, Bootz F, Garbe C, et al. Short German guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges. 2008(6 Suppl 1):S15–6.CrossRef
20.
Zurück zum Zitat Frohm ML, Griffith KA, Harms KL, Hayman JA, Fullen DR, Nelson CC, et al. Recurrence and survival in patients with Merkel cell carcinoma undergoing surgery without adjuvant radiation therapy to the primary site. JAMA Dermatol. 2016;152:1001–7.CrossRef Frohm ML, Griffith KA, Harms KL, Hayman JA, Fullen DR, Nelson CC, et al. Recurrence and survival in patients with Merkel cell carcinoma undergoing surgery without adjuvant radiation therapy to the primary site. JAMA Dermatol. 2016;152:1001–7.CrossRef
21.
Zurück zum Zitat Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol. 2016;23:3564–71.CrossRef Harms KL, Healy MA, Nghiem P, Sober AJ, Johnson TM, Bichakjian CK, et al. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system. Ann Surg Oncol. 2016;23:3564–71.CrossRef
22.
Zurück zum Zitat Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat. Oncol Biol Phys. 1995;31:325–31.CrossRef Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat. Oncol Biol Phys. 1995;31:325–31.CrossRef
Metadaten
Titel
Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?
verfasst von
Matthew C. Perez, MD
Felipe R. de Pinho, MD
Amanda Holstein, BS
Daniel E. Oliver, MD
Syeda M. H. Naqvi, MD, MPH
Youngchul Kim, PhD
Jane L. Messina, MD
Erin Burke, MD
Ricardo J. Gonzalez, MD
Amod A. Sarnaik, MD
C. Wayne Cruse, MD
Evan J. Wuthrick, MD
Louis B. Harrison, MD
Vernon K. Sondak, MD
Jonathan S. Zager, MD, FACS
Publikationsdatum
02.08.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6688-y

Weitere Artikel der Ausgabe 11/2018

Annals of Surgical Oncology 11/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.